Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.88
2.9937.90%
At close: -
$10.90
0.020.18%
After Hours: Jun 27, 7:59 PM EDT
Comments
Loading...
Eyenovia (EYEN) Forecast
NewsEarningsEyenovia (EYEN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Eyenovia Stock Price, Quotes and Forecasts | NASDAQ:EYEN | Benzinga
Explore Eyenovia stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EYEN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Eyenovia (EYEN) stock?
You can purchase shares of Eyenovia (NASDAQ:EYEN) through any online brokerage.
Who are Eyenovia (EYEN) competitors?
Other companies in Eyenovia’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Gelteq (NASDAQ:GELS) and SCYNEXIS (NASDAQ:SCYX).
What is the forecast, or price target, for Eyenovia (EYEN) stock?
Eyenovia has a consensus price target of $2.00.
What is the current price for Eyenovia (EYEN)?
The stock price for Eyenovia (NASDAQ: EYEN) is $10.9001 last updated June 27, 2025 at 7:59 PM EDT.
Does Eyenovia (EYEN) pay a dividend?
There are no upcoming dividends for Eyenovia.
When is Eyenovia (NASDAQ:EYEN) reporting earnings?
Eyenovia’s Q2 earnings are confirmed for Monday, August 11, 2025.
Is Eyenovia (EYEN) going to split?
There is no upcoming split for Eyenovia.
What sector and industry does Eyenovia (EYEN) operate in?
Eyenovia is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
